MAGE-1 (Target for Cancer Immunotherapy) (clone MZ2E/838 ), anti-human

MAGE-1 (Target for Cancer Immunotherapy) (clone MZ2E/838 ), anti-human

€0.00
In stock
SKU
AC-AH11783
Catalog Number: AC-AH11783
Size: 20 µg, 100 µg
Isotype: Mouse
Clone Name: MZ2E/838
Applications: IHC, IF, FC
Datasheet

Request Information
Background:
Recognizes a protein of 42-46kDa, identified as MAGE-1. This MAb does not cross-react with other members of MAGE-family. Human malignant neoplasms carry rejection antigens that are recognized by the patients' autologous, tumor directed and specific, cytolytic, CD8+ T lymphocyte clones (CTL). The MAGE family of genes codes an important group of antigens. It was identified that melanomas and primary glial brain tumors express common melanoma associated antigens (MAAs). Because MAGE-1 is expressed on a significant proportion of human neoplasms of various histological types (melanoma, brain tumors of glial origin, neuroblastoma, non-small cell lung cancer, breast, gastric, colorectal, ovarian, renal cell carcinomas) and not on normal tissues, the encoded antigen may serve as a marker of early detection and target for cancer immunotherapy.

Other Names:
Melanoma-associated antigen 1, Antigen MZ2-E, Cancer/testis antigen 1.1, CT1.1, MAGE-1 antigen, MAGEA1, MAGE1, MAGE1A

Gene Name: MAGEA1
Gene ID: 4100
Primary Accession: P43355
Other Accession: 4100, 72879
More Information
Is Featured? No
Write Your Own Review
You're reviewing:MAGE-1 (Target for Cancer Immunotherapy) (clone MZ2E/838 ), anti-human